Search Result "5 KWs."
Effect of Hsp90 Inhibitor KW-2478 on HepG2 Cells
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 19 Issue: 18 Year: 2019 Page: 2231-2242
Author(s): Xiaomin Chang,Xuerong Zhao,Jianping Wang,Shi Ding,Lijun Xiao,Enhong Zhao,Xin Zheng
Anti-Inflammatory Effect of KW-2449 on Autoimmune Encephalomyelitis: An Experimental Study on Mice
Journal: Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume: 21 Issue: 9 Year: 2021 Page: 1590-1597
Author(s): Hasan N. Ahmadabad,Allireza Abbaspour,Yaser Panahi,Saeed Tahmasebi,Nikoo Hossein-Khannazer,Sanaz Afraei,Hosein Miladi,Mahdi Goudarzvand,Ali N. Kamali,Yasser Bagheri,Reza Yazdani,Maria M. Di Fiore,Gholamreza Azizi
Structural Design of a 10 kW H-Darrieus Wind Turbine
Ebook: Mechanical Engineering Technologies and Applications
Volume: 1 Year: 2021
Author(s): Toufik Ouattas,Fateh Ferroudji,Soumia Benbouta
Phosphodiesterase-5 Inhibitors: Future Perspectives
Journal: Current Pharmaceutical Design
Volume: 15 Issue: 3 Year: 2009 Page: 3540-3551
Author(s): Giannitsas Konstantinos, Perimenis Petros
Targeting Interleukin (IL) 5 for Asthma and Hypereosinophilic Diseases
Journal: Recent Patents on Inflammation & Allergy Drug Discovery
Volume: 4 Issue: 3 Year: 2010 Page: 201-209
Author(s): Miguel L. Stein, Ariel Munitz
Therapeutic Potential of 5-HT7 Receptors in Mood Disorders
Journal: Current Drug Targets
Volume: 10 Issue: 1 Year: 2009 Page: 1109-1117
Author(s): Ouissame Mnie-Filali, Laura Lambas-Senas, Helene Scarna, Nasser Haddjeri
Heterogeneity Amongst 5-HT3 Receptor Subunits: Is this Significant?
Journal: Current Molecular Medicine
Volume: 11 Issue: 1 Year: 2011 Page: 57-68
Author(s): N. Yaakob, D. T. Malone, B. Exintaris, H. R. Irving
Inhibitors of 5α-Reductase in the Treatment of Benign Prostatic Hyperplasia
Journal: Current Pharmaceutical Design
Volume: 12 Issue: 7 Year: 2006 Page: 775-783
Author(s): T. H. Tarter, E. D. Vaughan Jr.
Prophylaxis of Erectile Function After Radical Prostatectomy with Phosphodiesterase Type 5 Inhibitors
Journal: Current Pharmaceutical Design
Volume: 15 Issue: 3 Year: 2009 Page: 3496-3501
Author(s): F. Deho, A. Gallina, A. Salonia, A. Briganti, N. Suardi, G. Zanni, G. Guazzoni, P. Rigatti, F. Montorsi
Transcriptional Dys-regulation in Anxiety and Major Depression: 5-HT1A Gene Promoter Architecture as a Therapeutic Opportunity
Journal: Current Pharmaceutical Design
Volume: 20 Issue: 2 Year: 2014 Page: 3738-3750
Author(s): Paul R. Albert, Laura M. Fiori